Simplify how you collect and use population-level data.
PolicyMap equips pharmaceutical and life science companies with reliable geospatial data, offering critical context to support strategic decision-making. With over 170 data sources, PolicyMap enables companies to navigate complex market dynamics and address community needs for a variety of business use cases. Drawing on trusted data spanning demographics, health indicators, and social factors, organizations can confidently align their strategies with real-world conditions. PolicyMap empowers organizations to make smarter, more impactful decisions that drive growth and innovation.
Quickly visualize disease trends and contributing factors. This map overlays cancer cases and incidence rates with co-morbidities like diabetes and risk factors such as high blood pressure. Gain insights into health outcomes and identify opportunities for new treatments. Click the map to enlarge.
Why Granular Data Matters
Granular insights at the census tract and block group levels offer a sharper view of population-specific needs, often hidden by broader zip code data. With PolicyMap’s precision, organizations can optimize trial site selection, refine outreach efforts, and craft equitable healthcare strategies, leading to better outcomes for underserved communities.
DEMO REQUEST
See PolicyMap In Action
Looking to explore our datasets or speak with an expert? Fill in the form to request a personalized demo and learn how PolicyMap can help your organization.
Who We Help
Pharma Organizations
Biotech Firms
CROs
Consultants
How We Help
Enhance Internal Intelligence
Access insights from PolicyMap’s extensive data warehouse through flexible subscriptions or bulk licensing via API or flat file. Integrate population-level data directly into your applications and platforms to better understand disease prevalence and identify at-risk populations, empowering more informed and strategic decisions.
Click the image to enlarge.
Assessing breast cancer rates among Black women and risk factors that could suggest later-stage diagnoses and higher death rates. Click to enlarge.
Champion Health Equity
Pharma teams can tackle disparities by analyzing social determinants, disease trends, and resource distribution to identify underserved areas. Use spatial insights to target interventions, optimize clinical trial outreach, and advocate for equitable policies. With location intelligence, drive impactful change and create a more inclusive healthcare landscape.
Inform Healthcare Policy & Government Affairs
Analyze health risks, treatment needs, and healthcare infrastructure to identify areas most impacted by policy changes. Use spatial data to craft data-driven strategies, support compliance, and align regulatory efforts with public health and business goals.
The map above is a hypothetical example identifying Congressional Districts in NJ that could benefit most from a prostate cancer screening bill. Click to enlarge.
Health Professional Shortage Areas (HPSAs) are defined by the Health Resources and Services Administration (HRSA) as areas that need more health providers in primary care, dental health, or mental health. All HPSAs are defined on the basis of three basic criteria: the ratio of population to health providers, percent of population below the federal poverty level, and travel time to the nearest source of care outside the HPSA area.
Expand Market Access
Leverage spatial data to dig deeper into regional healthcare landscapes, enabling more effective strategies for improving patient access and addressing disparities. Teams rely on PolicyMap to help identify underserved areas, assess the potential of new markets, and align their efforts with regional health needs and opportunities.
Design Inclusive Clinical Trials
Even without the FDA’s guidance, CROs have strong incentives to prioritize more inclusive clinical trials. Diverse trials yield data that better reflects real-world patient populations, improving the accuracy and applicability of study results.
Leverage spatial data to design inclusive trials by identifying underrepresented populations and addressing participation barriers. Analyze demographics, social determinants, and proximity to sites to improve access and representation.
Recruitment is a major challenge in clinical research. PolicyMap’s insights help researchers locate diverse populations and address barriers like healthcare access and transportation. Click the map to enlarge.
With PolicyMap’s custom regions, reps can visualize and/or access data for their unique sales territory. Identify areas with specialty physicians and high disease prevalence. Click the map to enlarge.
Accelerate Market Development & Optimize Sales Strategy
Leverage demographic and quality-of-life insights to uncover untapped opportunities, refine sales territories, and strategically distribute products. By mapping geographic trends in patient populations, disease prevalence, and healthcare access, pharmaceutical teams can expand their reach while aligning with the needs of patients and providers. Harness spatial data to accelerate decision-making, boost sales productivity, and streamline operations for a smarter, more impactful strategy.
Subscription Options
Maps, Data, Analytics, Reports & Dashboards
Mapping Platform
cloud-based; annual subscription for individual, team, or enterprise
Bulk Data Delivery
via flat file, API, or Snowflake
Embedded Maps
add our maps and data to your website
Partner Portal
provide access for your partners or members
Curated Collections of Data
Social Determinants of Health, Clean Energy
Insights & Client Solutions
consulting and custom development
WEBINAR
The Role of Geography in Healthcare
This session explores the transformative impact of spatial data and geospatial analysis in healthcare, from improving population health and system efficiency to driving innovation in life sciences and pharma.
